Mukhtar E D, Smith B R, Pyle G A, Hall R, Vice P
Lancet. 1975 Mar 29;1(7909):713-5. doi: 10.1016/s0140-6736(75)91629-3.
Thyroid-stimulating immunoglobulins (T.S.I.) have been detected in the serum of all patients with untreated Graves' disease, and in these patients the levels of T.S.I. correlated significantly with the early uptake of 131I by the thyroid. The frequency of T.S.I. in patients treated solely by antithyroid drugs, by radioiodine, or by partial thyroidectomy was 53 per cent, 50 per cent, and 17 per cent, respectively. The reduced frequency of T.S.I. in the serum of patients treated by drugs or radioiodine was probably due to spontaneous remission, but in the case of partial thyroidectomy the operation itself clearly had a dramatic effect on the serum-T.S;I. These results accorded well with the reported frequency of thyroid autonomy in similar groups of patients and suggested that thyroid-stimulating immunoglobulins were responsible for hyperthyroidism in Graves' disease.
在所有未经治疗的格雷夫斯病患者血清中均检测到促甲状腺素免疫球蛋白(T.S.I.),且在这些患者中,T.S.I.水平与甲状腺对131I的早期摄取显著相关。单纯接受抗甲状腺药物、放射性碘或部分甲状腺切除术治疗的患者中,T.S.I.的出现频率分别为53%、50%和17%。接受药物或放射性碘治疗的患者血清中T.S.I.频率降低可能是由于自发缓解,但对于部分甲状腺切除术而言,手术本身显然对血清T.S.I.有显著影响。这些结果与类似患者组中报道的甲状腺自主性频率相符,并表明促甲状腺素免疫球蛋白是格雷夫斯病中甲状腺功能亢进的原因。